Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from TYK Medicines, Inc. Class H ( (HK:2410) ).
TYK Medicines, Inc announced a placing agreement with a placing agent to sell 9,230,000 new H shares at HK$17.01 per share, representing a discount to recent trading prices. The placing is expected to raise approximately HK$154.73 million in net proceeds, which will be used as outlined in the company’s announcement. The shares will be placed with professional and institutional investors, and the placing does not require shareholder approval as it falls under a general mandate. The completion of the placing is subject to certain conditions, and there is no guarantee it will proceed.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
TYK Medicines, Inc is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on developing and distributing medicinal products and has a market presence in Hong Kong, as indicated by its stock code 2410.
Average Trading Volume: 2,950,639
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.24B
See more data about 2410 stock on TipRanks’ Stock Analysis page.